The synthesis process of the antitumor drug Entrectinib has been improved.Using 4-fluoro-2-nitrobenzoic acid as the starting material, 4-(4-methylpiperazin-1-yl)-2-[2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido] benzoic acid was obtained after esterification, nucleophilic substitution, reduction, nucleophilic addition, trifluoroacetyl protection, and hydrolysis.The product obtained after nucleophilic substitution of 2-fluoro-5-bromobenzonitrile and tri-Me borate was then subjected to Suzuki coupling reaction with 3,5-difluorobenzyl bromide.The product underwent ring formation to give 5-(3,5-difluorobenzyl)-1H-indazol-3-amine.4-(4-Methylpiperazin-1-yl)-2-[2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido] benzoic acid and 5-(3,5-difluorobenzyl)-1H-indazol-3-amine underwent condensation reaction to obtain the product, and then the trifluoroacetyl group was removed to obtain the target compound, purity 99.12%, total yield 26.0% (based on 4-fluoro-2-nitrobenzoic acid).Compared with the literature route, the synthesis process shortens the synthesis steps of the amide and synthesizes (3-cyano-4-fluorophenyl) boronic acid, an expensive raw material in the original process, saving costs, optimizing the conditions and post-treatment of the multi-step reaction method.The improved synthetic route has the characteristics of easy availability of raw materials, simple operation and high yield, and is more suitable for industrial production